Dehydropipernonaline



Compound IDCDAMM01005
Common nameDehydropipernonaline
IUPAC name9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnona-2,4,8-trien-1-one
Molecular formulaC21H25NO3

Experimental data

Retention time14.54
Adduct[M+Na]+
Actual mz362.176
Theoretical mz362.172
Error9.89
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.5308

Identifiers and class information

Inchi keyKAYVDASZRFLFRZ-PQECNABGSA-N
SmilesO=C(C=CC=CCCC=CC1=CC=C2OCOC2=C1)N3CCCCC3
SuperclassOrganoheterocyclic compounds
ClassBenzodioxoles

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)339.433
Computed dipole moment(dipole)3.422
Total solvent accessible surface area (SASA)678.094
Hydrophobic component of SASA (FOSA)449.983
Hydrophilic component of SASA (FISA)38.741
Pie component of the SASA (PISA)189.37
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1182.33
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)4.5
Free energy of solvation of dipole (dip^2/V)0.0099068
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.797446
Predicted polarizability in cubic angstroms (QPpolrz)38.477
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.83
Predicted octanol/gas partition coefficient (QPlogPoct)14.474
Predicted water/gas partition coefficient (QPlogPw)5.791
Predicted octanol/water partition coefficient (QPlogPo/w)4.771
Predicted aqueous solubility (QPlogS)-5.571
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.704
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.713
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)4251.27
Predicted brain/blood partition coefficient (QPlogBB)-0.265
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)2364.31
Predicted skin permeability, log Kp (QPlogKp)-0.894
PM3 calculated ionization potential (IP(ev))8.799
PM3 calculated electron affinity (EA(eV))0.457
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)0.549
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)47.15
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P27338MAOBMonoamine oxidase BT83011SwissTargetPrediction
P20701ITGALIntercellular adhesion molecule (ICAM-1), Integrin alpha-L/beta-2T35640SEA
P05362ICAM1Intercellular adhesion molecule-1T26203SEA
Q15078CDK5R1Cyclin-dependent kinase 5/CDK5 activator 1T09513SEA
Q00535CDK5Cyclin-dependent kinase 5/CDK5 activator 1T20973SEA
O75908SOAT2Acyl coenzyme A:cholesterol acyltransferase 2T14463SwissTargetPrediction
Q92630DYRK2Dual-specificity tyrosine-phosphorylation regulated kinase 2T39486SEA
P32249EBI2EBV-induced G-protein coupled receptor 2T59577SEA
Q7RTX1TAS1R1Taste receptorT41263SEA
Q15717ELAVL1ELAV-like protein 1T78349SEA
P05107ITGB2Integrin beta-2T10513SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83011DI0115Dementia[ICD-11: 6D80-6D8Z]P27338MAOB
T83011DI0117Depression[ICD-11: 6A70-6A7Z]P27338MAOB
T83011DI0190Hypertension[ICD-11: BA00-BA04]P27338MAOB
T83011DI0243Malaria[ICD-11: 1F40-1F45]P27338MAOB
T83011DI0264Migraine[ICD-11: 8A80]P27338MAOB
T83011DI0331Parkinsonism[ICD-11: 8A00]P27338MAOB
T35640DI0351Psoriasis[ICD-11: EA90]P20701ITGAL
T35640DI0436Visual system disease[ICD-11: 9E1Z]P20701ITGAL
T26203DI0436Visual system disease[ICD-11: 9E1Z]P05362ICAM1
T20973DI0308Obesity[ICD-11: 5B80-5B81]Q00535CDK5
T14463DI0017Adrenal cancer[ICD-11: 2D11]O75908SOAT2
T41263DI0078Cholera[ICD-11: 1A00]Q7RTX1TAS1R1
T10513DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P05107ITGB2

Copyright © 2025